- Home
- ZNTL vs FORR Comparison
ZNTL vs FORR Comparison
Compare ZNTL & FORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNTL | FORR |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 131.7M |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ZNTL | FORR |
|---|---|---|
| Price | $1.34 | $8.03 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $5.87 | N/A |
| AVG Volume (30 Days) | ★ 788.9K | 93.7K |
| Earning Date | 11-10-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $26,865,000.00 | ★ $403,871,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | $6.60 |
| 52 Week High | $3.33 | $16.10 |
Technical Indicators
Market Signals| Indicator | ZNTL | FORR |
|---|---|---|
| Relative Strength Index (RSI) | 45.28 | 65.69 |
| Support Level | $1.32 | $6.97 |
| Resistance Level | $1.46 | $7.57 |
| Average True Range (ATR) | 0.06 | 0.27 |
| MACD | -0.00 | 0.12 |
| Stochastic Oscillator | 23.53 | 90.83 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.